Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer
Clinical trial NCT06513364 · COMPLETED
Trial details
- NCT number
- NCT06513364
- Sponsor
- Beijing Wehand-Bio Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-10
- Primary completion
- 2025-08-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.